The term "evidence-based medicine" first appeared in the medical literature in 1992 and is in widespread use today. It is timely to examine the concept's relevance to anaesthetic practice as well as the validity of the premises on which it rests. An important difference between anaesthesia and the specialties which treat disease is that in anaesthesia there is very little research done with real outcomes as its end-point. Surrogate or intermediate outcomes predominate as the end-points of anaesthetic research, which is a weakness when the results serve as the evidence on which to base clinical decisions. Furthermore, in interventions which require personal skill, dexterity or decision-making, caution must be exercised in assuming that equally good outcomes are achievable by all. Key members of the Cochrane Collaboration, among the most prominent advocates of evidence-based medicine, promote the belief that much valid scientific evidence is to be found in sources outside the peer-reviewed published literature. This assertion must be treated with caution. Furthermore, some techniques central to the search for the evidence on which to base practice, including meta-analysis and multicentre trials, are prone to errors through incorrect application. Evidence-based medicine appears to have less to offer anaesthesia than it does to the "treating" specialties.
alternative approach, (iv) the method of comparison to be employed to compare the efficacies of the two approaches 3 . The time required to use all its possible applications far exceeds that available to any clinician for searching the literature for answers and the enthusiast has to determine how to best spend that precious time 4 .
EBM is an appealing concept. It is absolutely logical for physicians and surgeons to base their therapeutic and other clinical decisions on the best scientific evidence. Is it not equally reasonable to demand that anaesthetists also base all their decisions on the best scientific evidence? The answer, of course, is "yes". However, below are discussed some particular difficulties in applying the principles of EBM in anaesthesia as well as some general limitations of EBM and its techniques.
The Cochrane Collaboration
Particularly prominent among the protagonists of EBM has been the Cochrane Collaboration, an organization named after Professor Archie Cochrane, Director of the British Medical Research Council's Epidemiology and Pneumoconiosis Units in Wales in the 1960s 5 . In retirement Cochrane wrote on health care delivery and medical research and was a critic of current medical practice 6 . He advocated that a comprehensive catalogue of definitive reviews of scientifically valid clinical trials be compiled for each specialty to be consulted to assist with clinical decision-making and updated regularly. Medical interventions would thus be scientifically based on properly planned and executed clinical trials distilled where possible into equally scientifically valid reviews rather than on anecdote, habit, prejudice, selective experience, faulty memory or a skewed sample of the relevant clinical trials as is often the case.
While some clinicians see EBM as a threatening new method of medical practice, its advocates, including the Cochrane Collaboration, see it as no more than the natural and overdue alignment of medical practice with science 7 .
Difficulties in doing systematic reviews
Chalmers 5 , and Bero and Rennie 8 have drawn attention to difficulties in fulfilling Cochrane's dream and compiling systematic scientifically valid reviews. They stress how difficult it can be to locate all the relevant studies on any topic. A computer search may miss up to half because of inadequate indexing of papers, or limitations of the data base. According to Chalmers, stringent measures, including some manual searching outside the peer reviewed journals, must be taken to locate all the relevant material. They give reasons why clinical trials are under-reported, including: • failure of researchers to publish work done towards higher degrees other than in theses which have a negligible circulation. • failure to write a definitive paper once findings have been presented verbally and appeared in abstract form, and • failure of authors and editors to publish negative findings.
Chalmers argues that failure to publish negative findings leads to systematic bias in review articles which can flow on to inappropriate clinical practice.
Evidence outside the published peer-reviewed literature
It is a basic tenet of the Cochrane Collaboration that in order to write a valid review it is necessary to unearth all randomized controlled clinical trials relevant to the question including those hidden in the form of letters to the editor, abstracts, unsubmitted manuscripts and theses or unindexed conference proceedings 5 . This assertion is unsubstantiated where anaesthesia is concerned. Where is the evidence that researchers who have done important work and have it in a form suitable for submission as a thesis or oral presentation don't submit it for publication? When an author submits a worthy manuscript for publication and it is rejected, they submit it elsewhere until it is accepted. A manuscript which has been repeatedly rejected is unlikely to be a source of valid information. Those who scour Chalmers' hidden sources can expect a very poor return for their efforts. To accept evidence from non-peer-reviewed abstracts and letters to the editor as equal to that from peerreviewed journals is to dismiss the journals' review practices as worthless. To retrospectively set up an equal review mechanism for previously published letters and abstracts to decide whether their content is admissable as "evidence" would be a massive undertaking likely to yield no return.
The Cochrane philosophy has spread to many parts of the world, and since 1995 there has been an Australasian Cochrane Centre at the Flinders Medical Centre in Adelaide 7 .
Australian Cancer Network
There are other bodies with similar goals to those of the Cochrane Collaboration, for example the Australian Cancer Network (ACN). ACN's brief is to develop evidence-based guidelines for practitioners and consumer guides for patients in surgical oncology and related fields. It was formed in 1993 under More recently the ACN has published a booklet of recommendations on pathology reporting in breast cancer 11 . It is noteworthy that recommendations rather than guidelines were issued because the resource material available did not meet the standard required by the National Health and Medical Research Council for practice guidelines to be issued 12 . It is not stated whether this reflects a fundamental difference in the research which can ethically be done in surgery and anatomical pathology or just the current state of affairs in the latter.
Evidence-Based Medicine and Anaesthesia
Where does anaesthesia stand in relation to these worthy goals and initiatives? Should anaesthetists wholeheartedly embrace EBM? Are all decisions in anaesthesia to be supported by systematic reviews or, where such are lacking, by properly constructed randomized controlled trials? Should anaesthetists baulk at making clinical decisions based on intuition or clinical experience? (Note that in this context the related disciplines of intensive care medicine and pain therapy are not included under "anaesthesia"). Smith and Lodge of the Cochrane Collaboration's headquarters in Oxford, England, wrote in 1995 that the process of identifying and processing randomized clinical trials in anaesthesia was well under way with over 4000 identified 13 . However, little more has appeared in the anaesthetic literature. Why not?
An answer can be found in the difference between anaesthesia and the "therapeutic" specialties medicine and surgery in the range of outcomes by which to compare the efficacy of interventions. The range of outcomes by which to compare one technique of anaesthesia with another is limited 14 . In contrast, two surgical operations available to treat the same condition, e.g. coronary artery bypass grafting using saphenous vein grafts or using internal mammary artery grafts, can be compared using numerous measures of outcome, including • length of intensive care stay, • length of hospital stay, • requirement for blood transfusion, • rate of urgent reoperation for bleeding or pericardial tamponade, • graft survival, • incidence and severity of angina after operation, • survival measures.
Indices of outcome after anaesthesia are not nearly so discriminating. The commonest adverse outcomes of anaesthesia are minor, such as nausea and vomiting, headache, sore throat and thrombophlebitis. This is not to dismiss them as trivial, but merely to say that most are within the common range of human experience outside the anaesthetic and surgical setting and usually self-terminating. Awareness is always serious, even when the patient does not experience pain or distress. Seriously adverse outcomes, death or serious injury are rare today 15 .
Because the range of adverse outcomes of anaesthesia is so limited, investigators usually adopt intermediate or surrogate outcomes as end-points in clinical trials 16, 17 . Arbitrary levels of almost every known physiological variable have been used. A hypothetical example would be a study of the relative efficacies of several techniques of modulating the hypertensive response to laryngoscopy and endotracheal intubation. It is inferred that using the technique which meets the intermediate end-point of a lower peak blood pressure will be associated with better outcome in terms of reduced morbidity and even mortality. The outcome measured is a surrogate for a measure of real outcome.
The scarcity of information about the effects of anaesthetic interventions on absolute outcome contrasts markedly with the situation in medicine and surgery and limits the application of EBM to anaesthetic practice. There are few anaesthetic interventions for which recommendations can be made based on outcome evidence which would be classed level 1 or 2 evidence by the ACN. While Sackett and coauthors acknowledge that acceptable evidence for the practice of EBM is not restricted to randomized clinical trials and systematic reviews, they call the randomized clinical trial the "gold standard" and refer to other evidence, i.e. that classified by ACN as level 3 or 4, as "next best" 2 .
Evidence-Based Decisions in Anaesthesia: the Importance of Comparing Published Results With Local Experience
There are relatively few techniques in clinical anaesthesia which are based on the evidence of randomized controlled trials. For example, the universal use of Sellick's manoeuvre and rapid sequence induction in the patient at risk of regurgitation and pulmonary aspiration does not rest on such evidence. The more one moves away from a narrow definition of "anaesthetist" and embraces the therapeutic role of perioperative physician, the more often decisionmaking is based on the evidence of systematic reviews and scientific clinical trials. Thus there are two techniques associated with cardiac anaesthesia for which the anaesthetist functions as a specialist in perioperative transfusion medicine and for which extensive scientific evidence exists on which to base the decision whether or not to employ them; namely, • acute normovolaemic haemodilution and autologous transfusion, and • the prophylactic use of aprotinin.
Acute Normovolaemic Haemodilution (ANH)
ANH, the practice of collecting autologous blood at the beginning of cardiac surgery, replacing it with crystalloid or synthetic colloid, and re-infusing it after cardiopulmonary bypass has been in use for over 12 years with the aim of: 1) sparing the platelets in the collected blood from trauma in the bypass circuit thus enhancing haemostasis and reducing postoperative blood loss, 2) leading to the blood discarded with the bypass circuit having a relatively low haematocrit and conserving red cells, and 3) reducing the volume of homologous blood administered.
Numerous clinical trials have been done to investigate the efficacy of ANH, some of which have shown benefit while others have not. A review of the topic has appeared 18 , along with the position statement of the Consensus Conference on Autologous Transfusion, a multidisciplinary group of experts who concluded that there was little evidence to support the practice 19 . Their decision rests upon level 1 evidence by the ACN's grading.
Aprotinin
A related matter is the prophylactic administration of aprotinin to reduce postoperative blood loss in cardiac surgery. The association between aprotinin administration and reduced blood loss was first demonstrated by Royston and Bidstrup in patients undergoing repeat coronary artery bypass grafts (CABGs) 20 . There is a considerable volume of confirmatory evidence from clinical trials that the pre-and intraoperative administration of aprotinin significantly reduces postoperative blood loss and reduces in the requirement for homologous blood transfusion in primary CABG [21] [22] [23] . Similar benefit has been demonstrated for patients taking aspirin before cardiac surgery 24 , in heart transplantation 25 , and in surgery for infective endocarditis 26 . Dietrich has advocated the routine prophylactic use of aprotinin in cardiac surgery 22 .
Despite the level 1 and 2 evidence against the routine use of ANH and supporting the routine prophylactic use of aprotinin, in many cardiothoracic units, including that at the author's hospital, ANH is routine while aprotinin therapy is not. Are the anaesthetists concerned deliberately shunning an opportunity to practise evidence-based medicine?
For cardiac operations in 1996 at the author's hospital the mean drainage bottle blood loss was 528 ml, SD 357 ml (F. Junius, personal communication). The mean postoperative blood loss in the control group in Royston and Bidstrup's original trial was 1509 (SD 388) ml and in those who received aprotinin 286 (SD 48) ml. In Dietrich's 1995 paper the mean postoperative blood loss for patients who received aprotinin was 597 ml (range 448-794 ml) 27 . The control group's mean loss was 1500 ml (range 1125-1995 ml). Although clinical trials conclusively demonstrate the efficacy of aprotinin in reducing bleeding after coronary artery surgery, comparison with local findings leads to its use being restricted to certain cases likely to be associated with particularly large postoperative blood loss including cardiac transplantation in patients who have had previous cardiac surgery and in those with cyanotic congenital heart disease.
In the studies of ANH on which the Consensus Conference based its findings, mean postoperative blood loss and volume of homologous blood transfused in controls as well as in patients having ANH exceeded those at the author's hospital 18 . In a setting where ANH has been routine for over 10 years and mean postoperative blood loss is considerably less, there is no impetus to abandon the practice.
These two examples illustrate how evidence from clinical trials conducted elsewhere cannot necessarily be taken at face value and applied unquestioningly. To weigh the evidence it is necessary to compare it with accurate local information.
The Influence of the Operator and Local Systems in Surgical Outcome
Regardless of what evidence emerges from clinical trials on any particular question, what assurance is there that published outcomes are achievable by all? The question is particularly pertinent in matters where individual skill is involved.
In the surgical literature there are reports of outcome from different authors for many operations. Consider the practitioner seeking evidence from the literature as to the best management of the patient with advanced carotid and coronary artery disease in whom surgery on both is indicated. Among reports published during the last decade of over 100 cases of combined carotid endarterectomy and coronary artery bypass grafting, operative mortality rates vary from zero to 5.5%, stroke rates from 2.3 to 7.1%, and perioperative myocardial infarction rates from zero to 4.7% [28] [29] [30] [31] [32] [33] . Comparison of reports from various operators at different times is complicated by variations in case mix, in surgical technique and in the perioperative management of the patients. Furthermore it is likely that the published outcomes are among the better overall as the better the outcome the greater the incentive to publish.
Evidence in Colorectal Surgery
It is more instructive to look at the influence of the operator in a more controlled situation, e.g. within a prospective clinical trial. Two such studies are found in the British colorectal surgery literature.
Phillips and colleagues prospectively studied the local recurrence rate of cancer of the colon in patients operated on by 20 consultant surgeons who each entered more than 30 cases in 12 months 34 . Their local recurrence rates ranged from less than 5% to more than 20%.
McArdle and Hole studied the surgical outcome and complication rates in 645 patients who underwent curative bowel resection by 13 Scottish general surgeons 35 . There was a wide scatter in the results of the different surgeons in postoperative mortality (0-20%), anastomotic leak (0-25%), primary recurrence (0-21%), and 10 year survival (20-63%).
Rosen and colleagues surveyed 2805 colorectal operations using data from the Pennsylvania State Legislated Outcome Database 36 . They compared outcome for six board certified colorectal surgeons with that of 33 other surgeons. The in-hospital mortality for the board certified surgeons' patients was 1.4% versus 7.3% for the non-board certified.
It must be concluded that in surgery, who does the operation is most important. Not all surgeons pro-duce equal outcomes. What does the literature disclose about the individual anaesthetist's effect on outcome?
The Influence of the Anaesthetist on Outcome
One clinical trial was prompted by the belief that distension of the stomach with air in patients being manually ventilated prior to endotracheal intubation is an important factor influencing the incidence of postoperative emesis. The investigators tested the hypothesis that vomiting is more common when the person ventilating the patient's lungs is either an inexperienced anaesthetic trainee or an inexperienced trainee nurse anaesthetist, than when it is an experienced anaesthetist or nurse anaesthetist 37 . The findings supported the hypothesis.
Merry and colleagues studied the contribution of nine anaesthetists as risk factors in 1301 patients undergoing first-time coronary artery bypass grafting 38 . They accepted a serum aspartate aminotransferase concentration of greater than 100 units per litre on the day after operation as an index of myocardial damage and this or death was used to define an adverse outcome. There was a significant relationship between anaesthetist and adverse outcome. The only other factors significantly correlating with adverse outcome were the total bypass time and the aortic cross-clamp time 38 .
Slogoff and Keats investigated whether perioperative ischaemia in patients undergoing CABGs was related to postoperative myocardial infarction. They found that the anaesthetist whose patients had the highest incidence of tachycardia and ischaemia had the highest rate of postoperative myocardial infarction 39 . The only other factors which correlated with perioperative infarction were the ischaemic time and the surgeon's prospective assessment of the quality of the anastomoses.
Hence the literature supports the proposition that the patient's outcome can be adversely influenced by who gives the anaesthetic. Caution must be exercised in assuming that anyone can reproduce published outcomes, and hence that one technique will always have better outcomes than another just because it has the support of evidence from the literature.
Some of the techniques used to evaluate the evidence upon which EBM rests have pitfalls and can themselves introduce errors or at least ambiguity into the weighing of evidence.
Meta-Analyses
One technique used in analysing the evidence from numerous trials on the same topic is meta-analysis.
Many have appeared in the medical literature over recent years, a surprising number considering the stringent conditions for meta-analysis to be valid. For meta-analysis to be valid there must be prospective agreement on exclusions, end-points and the statistical analysis to be applied 40 . Stewart and Parmar demonstrated that the two techniques of metaanalysis of the literature and meta-analysis of individual patient data can lead to different conclusions which they attributed to publication bias, patient exclusion and different lengths of follow-up 41 . The correspondence which followed Sorenson and Pace's meta-analysis of mortality and morbidity associated with different techniques of anaesthesia for surgical repair of fractured neck of femur illustrate one difficulty in performing valid meta-analysis. The metaanalysis was flawed by two cases of multiple publication in the studies analysed of which the authors of the meta-analysis were unaware [42] [43] [44] .
Multicentre Trials
Evidence from multicentre trials also warrants particular scrutiny as they have their own pitfalls. The purpose of enrolling numerous centres in a trial when a rare phenomenon is being studied is to increase statistical power by increasing the number of cases studied. However, Dudley and colleagues noted 20 years ago that there can unintentionally be loss of standardization due to differences in management by different investigators, actually reducing the certainty of the findings 45 .
In conclusion it must be emphasized that it is not the aim of this paper to criticize the efforts of enthusiasts for EBM to extend the scientific basis of medical practice. This is obviously a worthy goal where it is feasible. Rather, attention has been drawn to some shortcomings of some of the techniques which underpin EBM, the importance of the individual clinician in interventions demanding judgement and skill has been highlighted, and the applicability of EBM to the practice of anaesthesia has been examined with the conclusion that it has less to offer this speciality than medicine and surgery.
Anaesthetists will continue to make most of their clinical decisions by matching evidence extrapolated from clinical trials utilizing surrogate end-points with their knowledge of pharmacology, physiology, medicine and surgery. The protagonists may claim that this is practising EBM but, if so, what is all the fuss about?
